KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Receivables - Other: 2021-2025

Historic Receivables - Other for Dynavax Technologies (DVAX) over the last 4 years, with Sep 2025 value amounting to $962,000.

  • Dynavax Technologies' Receivables - Other fell 50.49% to $962,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $962,000, marking a year-over-year decrease of 50.49%. This contributed to the annual value of $1.6 million for FY2024, which is 58.61% down from last year.
  • As of Q3 2025, Dynavax Technologies' Receivables - Other stood at $962,000, which was down 63.64% from $2.6 million recorded in Q2 2025.
  • In the past 5 years, Dynavax Technologies' Receivables - Other registered a high of $72.0 million during Q4 2022, and its lowest value of $519,000 during Q3 2023.
  • Moreover, its 3-year median value for Receivables - Other was $1.9 million (2024), whereas its average is $2.0 million.
  • In the last 5 years, Dynavax Technologies' Receivables - Other tumbled by 97.43% in 2022 and then surged by 274.37% in 2024.
  • Over the past 5 years, Dynavax Technologies' Receivables - Other (Quarterly) stood at $62.5 million in 2021, then grew by 15.10% to $72.0 million in 2022, then plummeted by 94.54% to $3.9 million in 2023, then tumbled by 58.61% to $1.6 million in 2024, then plummeted by 50.49% to $962,000 in 2025.
  • Its last three reported values are $962,000 in Q3 2025, $2.6 million for Q2 2025, and $1.6 million during Q1 2025.